RTI
Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic
and other biologic implants, recently donated several BioSet® RT
Allograft Paste implants to Lemoyne, Pa.-based CURE International. The
paste, a demineralized bone matrix (DBM), was used Sept. 18 during a
surgery to remove a large, benign cyst from the pelvic bone of an
11-year-old patient in San Pedro Sula, Honduras.
According to Ted Beemer, M.D., medical administrator/surgeon for CURE
Honduras, the cyst extended from the front of the patient's pelvic bone
to her sacroiliac joint and caused extreme pain, presumably due to the
weakening bone directly over the hip joint and adjacent to the
sacroliliac joint. The patient was confined to walking with crutches for
two months leading up to the surgery due to pain and fear of further
collapse of the bone around the hip joint. The donated allograft paste
was needed because obtaining sufficient autograft — tissue from one's
own body — risked weakening the side used for walking during the surgery
recovery period.
"The surgery went well, and I fully expect her to make a complete
recovery thanks to the substantial allograft donation by RTI," Beemer
said. "I am certain that her recovery would have been significantly
deterred if we had needed to take that much autologous bone from her
other side and/or lower extremities. In fact, she would have been
confined to a wheelchair for weeks instead of being able to walk with
crutches.
"We are very appreciative to RTI Biologics for its donation. It made a
huge difference in this child's treatment and will continue to affect
her recuperation."
Since it was established in 2004, CURE Honduras has provided
life-changing orthopedic treatment for thousands of children in
Honduras. The hospital, which does not turn away anyone under the age of
19, regardless of whether or not they can afford care, serves
approximately 4,500 patients each year and performs about 550 operations.
"Our mission at RTI is to improve lives through biologic solutions to
achieve life-restoring and life-saving results," said Brian K.
Hutchison, president and CEO. "Over the years, we have provided numerous
allograft donations such as this, and we will continue to do so. We take
great pride in playing a part in helping those in need return to their
normal activities."
Allograft is tissue surgically transplanted from one person to another.
Most allograft tissue is recovered surgically after someone dies. The
donor must have consented to the donation before death or the donor's
family must consent after death. Tissue transplantation can have many
benefits for recipients, including repairing tissue defects caused by
trauma or disease, restoring mobility and regaining independence in
daily activities. The selfless gift made by donors and their families
saves the quality of life for patients globally.
Allografts are used as an alternative to synthetic and metal implants.
However, unlike synthetic or metal implants, allografts are a natural
and biocompatible scaffold, allowing the recipient's body to remodel it
into his or her own tissue over time. Using allograft tissue rather than
an autograft eliminates a second surgical site, allowing the recipient
to avoid additional pain, risk and a possibly longer hospital stay. In
addition, in some cases, it is not possible to obtain an autograft, so
allografts are a natural solution.
RTI uses stringent donor screening, laboratory testing and proprietary, validated
sterilization processes to ensure patients' safety. These redundant
safeguards provide the highest level of confidence that patients will
receive safe, high quality tissue. RTI honors the gift of tissue
donation by treating the tissue with respect, by finding new ways to use
the tissue to help patients and by helping as many patients as possible
from each donation.